A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population With Pulmonary Arterial Hypertension
Phase of Trial: Phase I/II
Latest Information Update: 15 Jul 2017
At a glance
- Drugs Tadalafil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 31 Jan 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.
- 16 Jan 2017 Planned End Date changed from 1 Mar 2019 to 1 Sep 2019.